- Home
- EXK vs RCKT Comparison
EXK vs RCKT Comparison
Compare EXK & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXK
- RCKT
- Stock Information
- Founded
- EXK 1981
- RCKT 1999
- Country
- EXK Canada
- RCKT United States
- Employees
- EXK N/A
- RCKT N/A
- Industry
- EXK Precious Metals
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- EXK Basic Materials
- RCKT Health Care
- Exchange
- EXK Nasdaq
- RCKT Nasdaq
- Market Cap
- EXK 1.3B
- RCKT 1.3B
- IPO Year
- EXK N/A
- RCKT N/A
- Fundamental
- Price
- EXK $3.68
- RCKT $11.68
- Analyst Decision
- EXK Strong Buy
- RCKT Strong Buy
- Analyst Count
- EXK 4
- RCKT 11
- Target Price
- EXK $6.83
- RCKT $50.27
- AVG Volume (30 Days)
- EXK 5.9M
- RCKT 1.4M
- Earning Date
- EXK 11-05-2024
- RCKT 11-07-2024
- Dividend Yield
- EXK N/A
- RCKT N/A
- EPS Growth
- EXK N/A
- RCKT N/A
- EPS
- EXK N/A
- RCKT N/A
- Revenue
- EXK $225,927,000.00
- RCKT N/A
- Revenue This Year
- EXK $10.36
- RCKT N/A
- Revenue Next Year
- EXK $99.52
- RCKT $233,736.97
- P/E Ratio
- EXK N/A
- RCKT N/A
- Revenue Growth
- EXK N/A
- RCKT N/A
- 52 Week Low
- EXK $1.42
- RCKT $11.15
- 52 Week High
- EXK $5.67
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- EXK 35.25
- RCKT 31.91
- Support Level
- EXK $3.61
- RCKT $11.15
- Resistance Level
- EXK $3.82
- RCKT $12.87
- Average True Range (ATR)
- EXK 0.19
- RCKT 0.77
- MACD
- EXK -0.04
- RCKT -0.04
- Stochastic Oscillator
- EXK 7.29
- RCKT 13.77
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The company has three producing silver-gold mines in Mexico: the Guanacevi Mine in Durango, the Bolanitos Mine in Guanajuato and the El Compas Mine in Zacatecas. It also has three exploration projects in northern Chile: Aida project, Paloma project and the Cerro Marquez project.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.